Skip to main content

The Current Status of the Common Technical Document

  • Chapter
  • 697 Accesses

Abstract

The most significant regulatory initiative that the GCC member states have proactively implemented as part of their goal to standardise their regulatory systems is the Common Technical Document (CTD). The CTD format was adopted in all member states in January 2012 as part of the central registration procedure. This initiative reflected the assessment processes carried out by each individual authority and became the official review practice in all member states including Yemen. Pharmacovigilance (PV) and medicines communication has also been an important initiative by the GCC countries, but it has not yet been fully regulated to reach the European or US standards even though they base their PV initiatives on the European PV guidelines.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • American Pharmaceutical Group (APG). (2010). Ensuring access to essential medicines in developing countries. [Online] London: APG. Available from: www.apg.uk.com

  • CMR International Institute for Regulatory Science. (2009). Review and reimbursement: A special case for better cooperation. CMR International Institute for Regulatory Science Workshop, Surrey, 29–30 September. Surrey: CMR International. Available from: http://www.cmr.org/institute

  • Eichler, H., Pignatti, F., Bruno, F., Leufkens, H., & Breckenridge, A. (2008). Balancing early market access to new drugs with the need for benefit/risk data: A mounting dilemma. Nature Reviews Drug Discovery, 7, 818–826.

    Article  CAS  PubMed  Google Scholar 

  • Hashan, H. (2005). Evaluation of the review process for marketing pharmaceutical products in the Gulf states and its impact on patients’ access to medicines. Unpublished Doctor of Philosophy, The Welsh School of Pharmacy, Cardiff University.

    Google Scholar 

  • Matsebula, T., Goudge, J., & Gilson, L. (2005). Regulating the pharmaceutical sector: Coping with low capacity while maintaining regulatory independence. Health Economics Financing Programme (HEFP) Working Paper 01/05. [Online] South Africa: Centre for Health Policy, University of Witwatersrand. Available from: http://www.hefp.lshtm.ac.uk/publications/downloads/working_papers/01_05.pdf

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Al-Essa, R.K., Al-Rubaie, M., Walker, S., Salek, S. (2015). The Current Status of the Common Technical Document. In: Pharmaceutical Regulatory Environment. Adis, Cham. https://doi.org/10.1007/978-3-319-17590-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17590-4_5

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-17589-8

  • Online ISBN: 978-3-319-17590-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics